Zoraida Moreno Weidmann

Safety of the oral factor XIa inhibitor asundexian compared with apixaban in patients with atrial fibrillation (PACIFIC-AF): a multicentre, randomised, double-blind, double-dummy, dose-finding phase 2 study

Jonathan P. Piccini, Valeria Caso, Stuart J. Connolly et al. · The Lancet · 2022 · 296 citations · Full text

Thrombosis, Dose-finding Phase 2, Cardiovascular Disease +10

Prospective validation of a 1-hour algorithm to rule-out and rule-in acute myocardial infarction using a high-sensitivity cardiac troponin T assay

Tobias Reichlin, Raphael Twerenbold, Karin Wildi et al. · Canadian Medical Association Journal · 2015 · 225 citations · Full text

Optimal Cutoff Levels of More Sensitive Cardiac Troponin Assays for the Early Diagnosis of Myocardial Infarction in Patients With Renal Dysfunction

Raphael Twerenbold, Karin Wildi, Cédric Jaeger et al. · Circulation · 2015 · 208 citations · Full text

Misdiagnosis of Myocardial Infarction Related to Limitations of the Current Regulatory Approach to Define Clinical Decision Values for Cardiac Troponin

Karin Wildi, María Rubini Giménez, Raphael Twerenbold et al. · Circulation · 2015 · 133 citations · Full text

One-hour rule-in and rule-out of acute myocardial infarction using high-sensitivity cardiac troponin I

Cédric Jaeger, Karin Wildi, Raphael Twerenbold et al. · American Heart Journal · 2015 · 113 citations

Cardiovascular Disease, Myocardial Infarction, Cardiovascular Imaging +8